You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

VALIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Valium, and what generic alternatives are available?

Valium is a drug marketed by Roche and Waylis Therap and is included in two NDAs.

The generic ingredient in VALIUM is diazepam. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diazepam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Valium

A generic version of VALIUM was approved as diazepam by MYLAN on September 4th, 1985.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VALIUM?
  • What are the global sales for VALIUM?
  • What is Average Wholesale Price for VALIUM?
Drug patent expirations by year for VALIUM
Drug Prices for VALIUM

See drug prices for VALIUM

Recent Clinical Trials for VALIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 1/Phase 2
Ontario Ministry of Health and Long Term CareN/A
Canadian Institutes of Health Research (CIHR)N/A

See all VALIUM clinical trials

Pharmacology for VALIUM
Drug ClassBenzodiazepine

US Patents and Regulatory Information for VALIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche VALIUM diazepam INJECTABLE;INJECTION 016087-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-006 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VALIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche VALIUM diazepam INJECTABLE;INJECTION 016087-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-004 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Waylis Therap VALIUM diazepam TABLET;ORAL 013263-006 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.